A novel B lymphocyte-associated adaptor protein, Bam32, regulates antigen receptor signaling downstream of phosphatidylinositol 3-kinase

Aaron J. Marshall, Hiroaki Niiro, Cara G. Lerner, Theodore J. Yun, Sushma Thomas, Christine M. Disteche, Edward A. Clark

Research output: Contribution to journalArticle

77 Citations (Scopus)

Abstract

We have identified and characterized a novel src homology 2 (SH2) and pleckstrin homology (PH) domain-containing adaptor protein, designated Bam32 (for B cell adaptor molecule of 32 kD). cDNAs encoding the human and mouse Bam32 coding sequences were isolated and the human bam32 gene was mapped to chromosome 4q25-q27. Bam32 is expressed by B lymphocytes, but not T lymphocytes or nonhematopoietic cells. Human germinal center B Cells show increased Bam32 expression, and resting B cells rapidly upregulate expression of Bam32 after ligation of CD40, but not immunoglobulin M. Bam32 is tyrosine- phosphorylated upon B cell antigen receptor (BCR) ligation or pervanadate stimulation and associates with phospholipase Cγ2. After BCR ligation, Bam32 is recruited to the plasma membrane through its PH domain. Membrane recruitment requires phosphatidylinositol 3-kinase (PI3K) activity and an intact PI(3,4,5)P3-binding motif, suggesting that membrane association occurs through binding to 3-phosphoinositides. Expression of Bam32 in B cells leads to a dose-dependent inhibition of BCR-induced activation of nuclear factor of activated T cells (NF-AT), which is blocked by deletion of the PH domain or mutation of the PI(3,4,5)P3-binding motif. Thus, Bam32 represents a novel B cell-associated adaptor that regulates BCR signaling downstream of PI3K.

Original languageEnglish
Pages (from-to)1319-1331
Number of pages13
JournalJournal of Experimental Medicine
Volume191
Issue number8
DOIs
Publication statusPublished - Apr 17 2000
Externally publishedYes

Fingerprint

Phosphatidylinositol 3-Kinase
Antigen Receptors
B-Lymphocytes
B-Cell Antigen Receptors
Ligation
IgA receptor
NFATC Transcription Factors
Germinal Center
Membranes
Phospholipases
Phosphatidylinositols

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology

Cite this

A novel B lymphocyte-associated adaptor protein, Bam32, regulates antigen receptor signaling downstream of phosphatidylinositol 3-kinase. / Marshall, Aaron J.; Niiro, Hiroaki; Lerner, Cara G.; Yun, Theodore J.; Thomas, Sushma; Disteche, Christine M.; Clark, Edward A.

In: Journal of Experimental Medicine, Vol. 191, No. 8, 17.04.2000, p. 1319-1331.

Research output: Contribution to journalArticle

Marshall, Aaron J. ; Niiro, Hiroaki ; Lerner, Cara G. ; Yun, Theodore J. ; Thomas, Sushma ; Disteche, Christine M. ; Clark, Edward A. / A novel B lymphocyte-associated adaptor protein, Bam32, regulates antigen receptor signaling downstream of phosphatidylinositol 3-kinase. In: Journal of Experimental Medicine. 2000 ; Vol. 191, No. 8. pp. 1319-1331.
@article{3b65c9ba34514da9aac20b676d0400e1,
title = "A novel B lymphocyte-associated adaptor protein, Bam32, regulates antigen receptor signaling downstream of phosphatidylinositol 3-kinase",
abstract = "We have identified and characterized a novel src homology 2 (SH2) and pleckstrin homology (PH) domain-containing adaptor protein, designated Bam32 (for B cell adaptor molecule of 32 kD). cDNAs encoding the human and mouse Bam32 coding sequences were isolated and the human bam32 gene was mapped to chromosome 4q25-q27. Bam32 is expressed by B lymphocytes, but not T lymphocytes or nonhematopoietic cells. Human germinal center B Cells show increased Bam32 expression, and resting B cells rapidly upregulate expression of Bam32 after ligation of CD40, but not immunoglobulin M. Bam32 is tyrosine- phosphorylated upon B cell antigen receptor (BCR) ligation or pervanadate stimulation and associates with phospholipase Cγ2. After BCR ligation, Bam32 is recruited to the plasma membrane through its PH domain. Membrane recruitment requires phosphatidylinositol 3-kinase (PI3K) activity and an intact PI(3,4,5)P3-binding motif, suggesting that membrane association occurs through binding to 3-phosphoinositides. Expression of Bam32 in B cells leads to a dose-dependent inhibition of BCR-induced activation of nuclear factor of activated T cells (NF-AT), which is blocked by deletion of the PH domain or mutation of the PI(3,4,5)P3-binding motif. Thus, Bam32 represents a novel B cell-associated adaptor that regulates BCR signaling downstream of PI3K.",
author = "Marshall, {Aaron J.} and Hiroaki Niiro and Lerner, {Cara G.} and Yun, {Theodore J.} and Sushma Thomas and Disteche, {Christine M.} and Clark, {Edward A.}",
year = "2000",
month = "4",
day = "17",
doi = "10.1084/jem.191.8.1319",
language = "English",
volume = "191",
pages = "1319--1331",
journal = "Journal of Experimental Medicine",
issn = "0022-1007",
publisher = "Rockefeller University Press",
number = "8",

}

TY - JOUR

T1 - A novel B lymphocyte-associated adaptor protein, Bam32, regulates antigen receptor signaling downstream of phosphatidylinositol 3-kinase

AU - Marshall, Aaron J.

AU - Niiro, Hiroaki

AU - Lerner, Cara G.

AU - Yun, Theodore J.

AU - Thomas, Sushma

AU - Disteche, Christine M.

AU - Clark, Edward A.

PY - 2000/4/17

Y1 - 2000/4/17

N2 - We have identified and characterized a novel src homology 2 (SH2) and pleckstrin homology (PH) domain-containing adaptor protein, designated Bam32 (for B cell adaptor molecule of 32 kD). cDNAs encoding the human and mouse Bam32 coding sequences were isolated and the human bam32 gene was mapped to chromosome 4q25-q27. Bam32 is expressed by B lymphocytes, but not T lymphocytes or nonhematopoietic cells. Human germinal center B Cells show increased Bam32 expression, and resting B cells rapidly upregulate expression of Bam32 after ligation of CD40, but not immunoglobulin M. Bam32 is tyrosine- phosphorylated upon B cell antigen receptor (BCR) ligation or pervanadate stimulation and associates with phospholipase Cγ2. After BCR ligation, Bam32 is recruited to the plasma membrane through its PH domain. Membrane recruitment requires phosphatidylinositol 3-kinase (PI3K) activity and an intact PI(3,4,5)P3-binding motif, suggesting that membrane association occurs through binding to 3-phosphoinositides. Expression of Bam32 in B cells leads to a dose-dependent inhibition of BCR-induced activation of nuclear factor of activated T cells (NF-AT), which is blocked by deletion of the PH domain or mutation of the PI(3,4,5)P3-binding motif. Thus, Bam32 represents a novel B cell-associated adaptor that regulates BCR signaling downstream of PI3K.

AB - We have identified and characterized a novel src homology 2 (SH2) and pleckstrin homology (PH) domain-containing adaptor protein, designated Bam32 (for B cell adaptor molecule of 32 kD). cDNAs encoding the human and mouse Bam32 coding sequences were isolated and the human bam32 gene was mapped to chromosome 4q25-q27. Bam32 is expressed by B lymphocytes, but not T lymphocytes or nonhematopoietic cells. Human germinal center B Cells show increased Bam32 expression, and resting B cells rapidly upregulate expression of Bam32 after ligation of CD40, but not immunoglobulin M. Bam32 is tyrosine- phosphorylated upon B cell antigen receptor (BCR) ligation or pervanadate stimulation and associates with phospholipase Cγ2. After BCR ligation, Bam32 is recruited to the plasma membrane through its PH domain. Membrane recruitment requires phosphatidylinositol 3-kinase (PI3K) activity and an intact PI(3,4,5)P3-binding motif, suggesting that membrane association occurs through binding to 3-phosphoinositides. Expression of Bam32 in B cells leads to a dose-dependent inhibition of BCR-induced activation of nuclear factor of activated T cells (NF-AT), which is blocked by deletion of the PH domain or mutation of the PI(3,4,5)P3-binding motif. Thus, Bam32 represents a novel B cell-associated adaptor that regulates BCR signaling downstream of PI3K.

UR - http://www.scopus.com/inward/record.url?scp=0034678458&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034678458&partnerID=8YFLogxK

U2 - 10.1084/jem.191.8.1319

DO - 10.1084/jem.191.8.1319

M3 - Article

C2 - 10770799

AN - SCOPUS:0034678458

VL - 191

SP - 1319

EP - 1331

JO - Journal of Experimental Medicine

JF - Journal of Experimental Medicine

SN - 0022-1007

IS - 8

ER -